SIRT1 and head and neck cancer: This molecule is likely to be protumorigenic in lung, breast, gastric, colon, liver, pancreatic, ovarian, cervical, prostate, and skin cancers13, whereas in head and neck cancers, the roles of Sirt1 remain ambiguous, with some studies reporting Sirt1 upregulation and others reporting downregulation14,15.